Detalles de la búsqueda
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952217
2.
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 149(23): 1789-1801, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583093
3.
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
Ann Intern Med
; 177(4): 476-483, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498876
4.
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination.
J Infect Dis
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717928
5.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
6.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830208
7.
Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: Prespecified Analysis of the NUDGE-FLU Trial.
Circulation
; 147(18): 1345-1354, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871213
8.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36876483
9.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342789
10.
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
Lancet
; 401(10382): 1103-1114, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889332
11.
Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season.
Am Heart J
; 272: 23-36, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460754
12.
Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial.
J Card Fail
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802053
13.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683911
14.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104937
15.
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
Diabetes Obes Metab
; 26(5): 1821-1829, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586966
16.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210743
17.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220172
18.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 146(16): 1210-1224, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029465
19.
Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
Stroke
; 54(11): 2766-2775, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37800372
20.
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet
; 400(10354): 757-767, 2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041474